Carnosine
Anti-glycation dipeptide studied for blood sugar and brain ageing.
What is Carnosine?
Carnosine (L-Carnosine) is a longevity supplement used for modest blood-sugar lowering. NutriDex grades the human evidence as Moderate. Carnosine is a dipeptide of β-alanine and histidine concentrated in muscle and brain, where it buffers acid, scavenges free radicals and limits glycation (sugar-protein damage linked to ageing). In humans the best evidence is metabolic: pooled RCTs show carnosine lowers HbA1c by roughly 0.9% and modestly reduces fasting glucose and insulin resistance in people with prediabetes or type 2 diabetes, and a 2024 RCT found flatter post-meal glucose curves on 2 g/day. A cognition meta-analysis found carnosine/anserine improved delayed-recall memory and global cognition in older adults, and a separate analysis reported reduced depression scores. Effects on core autism symptoms were not confirmed. Caveats are substantial: trials are small and short, oral carnosine is rapidly broken down by serum carnosinase, and long-term, hard-outcome data (events, lifespan) do not exist. It appears safe at studied doses.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| HbA1c loweringMultiple meta-analyses converge on ~0.9% HbA1c reduction in pre/diabetes; trials small and short. | Moderate | ↑ benefit · moderate | 2 |
| Fasting glucose / insulin resistanceOne meta-analysis showed fasting-glucose and HOMA-IR benefit; another found no significant change. | Mixed | ↔ mixed · small | 2 |
| Postprandial glucoseSingle 2024 RCT (n=43) flattened OGTT glucose curve at 2 g/day; needs replication. | Preliminary | ↑ benefit · moderate | 1 |
| Memory (delayed recall) / cognitionMeta-analyses show improved delayed recall/global cognition but no effect on MMSE or ADAS-Cog. | Moderate | ↑ benefit · small | 2 |
| Depressive symptomsAn 18-RCT meta-analysis found reduced depression scores, but an earlier one found no effect; inconsistent. | Mixed | ↔ mixed · small | 2 |
| Autism core symptomsMeta-analysis of 3 RCTs found no significant CARS benefit; evidence does not support use. | Moderate | — no effect · negligible | 1 |